Found 813 clinical trials
Study of NUEDEXTA in the Treatment of Pseudobulbar Affect (PBA)
Study of NUEDEXTA in the Treatment of Pseudobulbar Affect (PBA)
- 90 views
- 23 Nov, 2020
- 1 location
Adolescent Asthma (12 to 17 year old)
A research study is now underway in the Miami area and is seeking participants with Asthma that are between 12 to 17 years old.
- 32 views
- 23 Nov, 2020
- 1 location
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age with Chronic Migraine – the REBUILD-2 Study
This study will help us learn more about a study drug called galcanezumab. We are testing this study drug to find out if it is safe and effective at helping adolescents who have chronic migraine headaches.
- 0 views
- 27 Jan, 2021
- 1 location
A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients
A Phase 1/2, Open Label, Dose Ranging Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of PRX-102 Administered by Intravenous Infusion Every 2 Weeks for 12 Weeks to Adult Fabry Patients
- 182 views
- 08 Nov, 2020
- 1 location
If you are an adolescent or adult at least 12 years of age and have facial acne, please contact Coastal Carolina Research Center about our new medical research study.
If you are an adolescent or adult at least 12 years of age and have facial acne, please contact Coastal Carolina Research Center about our new medical research study.
- 212 views
- 23 Nov, 2020
- 1 location
Allergic Contact Dermatitis study for 12-54 years of age
Have you been suffering with Allergic Contact Dermatitis (skin rash, hives, etc.) We have a new trial opening for children and adults who have been diagnosed with moderate to severe Allergic Contact Dermatitis. A free evaluation is available to see if you qualify.
- 273 views
- 05 Jun, 2020
- 1 location
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the effect of secukinumab on aortic vascular inflammation and cardiometabolic biomarkers after 12 weeks of treatment, compared to placebo, and up to 52 weeks of treatment with secukinumab in adult subjects with moderate to severe chronic plaque-type psoriasis
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate the effect of secukinumab on aortic vascular inflammation and cardiometabolic biomarkers after 12 weeks of treatment, compared to placebo, and up to 52 weeks of treatment with secukinumab in adult subjects with moderate to severe chronic plaque-type psoriasis
- 372 views
- 23 Nov, 2020
- 1 location
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF) SOCRATES-PRESERVED
A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF) SOCRATES-PRESERVED
- 522 views
- 08 Nov, 2020
- 1 location
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12)
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 versus docetaxel in patients who have been previously treated for metastatic NSCLC with a KRAS G12C mutation.
- 0 views
- 16 Jul, 2021
- 38 locations
Pilot: Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder
Pilot: Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder
- 732 views
- 23 Nov, 2020
- 1 location